S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
NASDAQ:INO

Inovio Pharmaceuticals Insider Trades

$6.60
-0.64 (-8.84%)
(As of 12/1/2021 04:00 PM ET)
Add
Compare
Today's Range
$6.60
▼
$7.21
50-Day Range
$6.36
▼
$8.03
52-Week Range
$5.81
▼
$19.00
Volume
5.91 million shs
Average Volume
8.08 million shs
Market Capitalization
$1.39 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.59

Inovio Pharmaceuticals (NASDAQ:INO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.90%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
8

Amount Of
Insider Selling
(Last 12 Months)
$5.26 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get INO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inovio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Inovio Pharmaceuticals (NASDAQ INO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/9/2021Jacqueline Elizabeth SheaCOOSell38,535$10.01$385,735.3521,592  
6/9/2021Laurent HumeauInsiderSell10,318$9.07$93,584.2678,904  
6/9/2021Peter KiesCFOSell33,750$10.01$337,837.50164,538  
6/3/2021Peter KiesCFOSell10,000$8.03$80,300.00150,788  
5/17/2021Lota S ZothDirectorSell2,045$6.62$13,537.9023,932  
4/21/2021David B. WeinerDirectorSell26,583$8.57$227,816.31877,719  
4/21/2021Peter KiesCFOSell10,000$8.52$85,200.00160,788  
4/16/2021Simon X BenitoDirectorSell2,000$8.75$17,500.0053,650  
3/26/2021Jacqueline Elizabeth SheaCOOSell4,710$8.97$42,248.7072,084  
3/16/2021Simon X BenitoDirectorSell2,000$10.41$20,820.00
3/12/2021Jacqueline Elizabeth SheaCOOSell16,881$10.06$169,822.8698,272  
3/9/2021David B WeinerDirectorSell7,000$9.39$65,730.00
2/3/2021Jong Joseph KimCEOSell62,500$14.24$890,000.001,078,313  
2/1/2021Jacqueline Elizabeth SheaCOOSell28,336$15.05$426,456.8066,871  
2/1/2021Jong Joseph KimCEOSell100,000$15.00$1,500,000.001,078,313  
1/28/2021Jacqueline Elizabeth SheaCOOSell16,713$12.04$201,224.5234,296  
1/15/2021Peter KiesCFOSell30,000$10.02$300,600.00149,290  
12/15/2020David B WeinerDirectorSell17,500$10.71$187,425.00844,719  
12/15/2020Peter KiesCFOSell20,000$10.69$213,800.00128,040  
8/10/2020Laurent HumeauInsiderSell19,467$19.06$371,041.0243,966  
7/30/2020Jong Joseph KimCEOSell100,000$21.13$2,113,000.001,188,313  
7/15/2020Peter KiesCFOSell35,000$24.95$873,250.00154,290  
6/30/2020Peter KiesCFOSell35,000$26.50$927,500.00119,290  
6/22/2020Laurent HumeauInsiderSell19,467$14.70$286,164.9063,433  
5/11/2020David B WeinerDirectorSell2,404$11.84$28,463.36827,219  
3/12/2020David B WeinerDirectorSell3,500$11.14$38,990.00828,610  
3/10/2020David B WeinerDirectorSell3,500$9.32$32,620.00828,610  
1/13/2020Jong Joseph KimCEOBuy22,500$3.11$69,975.001,100,707  
8/30/2019Laurent HumeauInsiderBuy4,500$2.22$9,990.0050,333  
8/1/2019David B WeinerDirectorSell16,352$2.72$44,477.44797,110  
6/5/2019Laurent HumeauInsiderBuy20,000$2.50$50,000.0045,833  
6/3/2019Jong Joseph KimCEOSell2,129,553$2.36$5,025,745.081,911,055  
5/31/2019Jong Joseph KimCEOSell500,000$2.44$1,220,000.001,911,055  
5/21/2019Jong Joseph KimCEOSell100,000$3.31$331,000.002,411,055  
5/16/2019Jong Joseph KimCEOSell136,768$3.50$478,688.002,511,055  
11/29/2018Peter KiesCFOSell10,001$5.28$52,805.2872,089  
9/12/2018Jong Joseph KimCEOSell49,060$5.37$263,452.202,357,554  
7/10/2018Peter KiesCFOSell35,000$4.44$155,400.0097,088  
4/16/2018David B WeinerDirectorSell9,000$4.91$44,190.00758,956  
4/12/2018Jong Joseph KimCEOSell103,750$5.14$533,275.002,395,557  
4/12/2018Simon X BenitoDirectorSell3,750$5.23$19,612.5031,548  
5/25/2017David B WeinerDirectorSell8,000$8.00$64,000.00740,956  
3/31/2017Jong Joseph KimCEOSell147,180$6.54$962,557.202,164,887  
3/27/2017Morton CollinsDirectorBuy21,300$6.25$133,125.00142,291  
8/29/2016Niranjan SardesaiCOOSell21,800$9.30$202,740.0070,234  
6/28/2016Morton CollinsDirectorBuy10,000$9.13$91,300.00142,291  
5/18/2016Simon X BenitoDirectorSell6,250$10.37$64,812.5024,048  
4/15/2016Morton CollinsDirectorBuy68,400$9.52$651,168.00127,291  
9/30/2015Niranjan SardesaiCOOBuy4,000$5.50$22,000.0032,000  
8/14/2015Simon X BenitoDirectorBuy6,000$7.21$43,260.00  
4/13/2015Angel CabreraDirectorBuy8,000$9.53$76,240.00  
10/9/2014Peter KiesCFOBuy3,960$10.10$39,996.00  
8/21/2014Morton CollinsDirectorBuy8,000$10.01$80,080.00  
8/20/2014Morton CollinsDirectorBuy40,600$9.74$395,444.00  
8/12/2014Jong Joseph KimCEOBuy250,000$9.06$2,265,000.00  
8/12/2014Niranjan SardesaiCOOBuy2,550$8.70$22,185.00  
4/15/2014Jong Joseph KimCEOBuy25,000$2.25$56,250.005,965,809  
11/13/2013Morton CollinsDirectorBuy254,500$1.82$463,190.00655,864  
4/16/2013Mark BagarazziInsiderBuy60,000$0.56$33,600.00  
4/2/2013Jong Joseph KimCEOBuy90,000$0.50$45,000.00  
3/22/2013Angel CabreraDirectorBuy40,000$0.54$21,600.00  
3/20/2013Jong Joseph KimCEOBuy60,000$0.53$31,800.00  
3/20/2013Niranjan SardesaiCOOBuy25,000$0.53$13,250.00  
1/15/2013Morton CollinsDirectorBuy100,000$0.67$67,000.00  
11/14/2012Austin W & Greenhouse Da MarxeMajor ShareholderSell622,550$0.53$329,951.50  
8/15/2012Angel CabreraDirectorBuy75,000$0.59$44,250.00  
(Data available from 1/1/2013 forward)












Inovio Pharmaceuticals (NASDAQ:INO) Insider Trade Frequently Asked Questions

Who is on Inovio Pharmaceuticals's Insider Roster?

The list of insiders at Inovio Pharmaceuticals includes David B Weiner, Jacqueline Elizabeth Shea, Jong Joseph Kim, Laurent Humeau, Lota S Zoth, Peter Kies, and Simon X Benito.Learn more on INO's insiders

What percentage of Inovio Pharmaceuticals stock is owned by insiders?

2.90% of Inovio Pharmaceuticals stock is owned by insiders. Learn more on INO's insider holdings

Which Inovio Pharmaceuticals insiders have been buying company stock?

The following insider purchased Inovio Pharmaceuticals stock in the last 24 months: Jong Joseph Kim ($69,975.00).

How much insider buying is happening at Inovio Pharmaceuticals?

Insiders have purchased a total of 22,500 Inovio Pharmaceuticals shares in the last 24 months for a total of $69,975.00 bought.

Which Inovio Pharmaceuticals insiders have been selling company stock?

The following insiders have sold Inovio Pharmaceuticals stock in the last 24 months: David B Weiner ($353,228.36), Jacqueline Elizabeth Shea ($1,225,488.23), Jong Joseph Kim ($4,503,000.00), Laurent Humeau ($750,790.18), Lota S Zoth ($13,537.90), Peter Kies ($2,818,487.50), and Simon X Benito ($38,320.00).

How much insider selling is happening at Inovio Pharmaceuticals?

Insiders have sold a total of 657,209 Inovio Pharmaceuticals shares in the last 24 months for a total of $9,930,668.48 sold.

This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.